EYE vs LDX

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

58MEDIUM

LDX

LUMOS FPO [LDX]

56MEDIUM

Score Breakdown

EYE LDX
Technical
46
43
Catalyst
54
51
Sentiment
50
50
Fundamental
60
76
Momentum
65
47
Risk Gate
50
50

Key Metrics

EYE Metric LDX
$38.5MMarket Cap$91.6M
199KAvg Volume (20d)937K
N/AShort InterestN/A
$0.20552-Week High$0.330
$0.10052-Week Low$0.076
+3.8%Daily Change-3.0%
$0.135Reference Price$0.097
-26.1%ROE-34.1%
-12.4%Profit Margin-37.5%

Active Signals

EYE Signals

Stochastic just turned bullish from a low level — early reversal sign
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.2 quarters)
Low P/S ratio (1.1x)
Moderate revenue growth (+11%)
EPS estimates revised upward (+10pts)
Small-cap ($20-100M)

LDX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare EYE and LDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs LGP →EYE vs SPL →IMM vs NOX →CGS vs SPL →AHC vs NOX →
EYE Full Analysis → LDX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).